Brevan Howard Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-30,953
| Closed | -$539K | – | 1416 |
|
|
2024
Q4 | $539K | Sell |
30,953
-30,742
| -50% | -$536K | ﹤0.01% | 564 |
|
|
2024
Q3 | $863K | Buy |
61,695
+400
| +0.7% | +$5.6K | 0.01% | 445 |
|
|
2024
Q2 | $504K | Buy |
61,295
+12,701
| +26% | +$104K | ﹤0.01% | 555 |
|
|
2024
Q1 | $375K | Buy |
48,594
+25,553
| +111% | +$197K | ﹤0.01% | 517 |
|
|
2023
Q4 | $207K | Buy |
+23,041
| New | +$207K | ﹤0.01% | 823 |
|